noom with glp 1 Unveils Two New Enterprise Products to Help Employers Noom introduces longevity-focused GLP-1 microdosing

Alcohol Alcohol can be tricky on its own for people with diabetes, but GLP-1 medications add another layer

Triple agonists like retatrutide are emerging as next-generation options with potentially different side effect profiles

GLP-1 and underlying beneficial actions in Alzheimer's disease, hypertension, and NASH

The World Anti-Doping Agency is watching

FDA has stated that compounded GLP-1 products are not FDA-approved finished products and has continued enforcement activity against misleading promotion of non-FDA-approved compounded versions as though they were the same as FDA-approved drugs

If stability is not achieved, your provider may recommend restarting at a lower dose, switching to an alternative agent, or extending behavioral support indefinitely